Delivery Order SPE2DB20D2014-SPE2DB25FC88R
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,990.63 to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 mL pens on August 18, 2025, with an ultimate completion date of August 19, 2025. This competitively awarded, firm fixed-price delivery order was issued without a set-aside designation and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement under...
- The Defense Logistics Agency awarded a delivery order contract valued at $1,596.50 to AmerisourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 mL pen (0.5 mL) on July 28, 2025. This is a firm fixed price, non-set-aside delivery order that will be performed in Conshohocken, Pennsylvania, with an ultimate completion date of July 29, 2025. The contract represents a single delivery of this diabetes treatment medication to support federal medical procurement needs. This delivery order falls...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,308.60 for Zepbound 10 mg/0.5 ml pens on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a procurement of the injectable diabetes medication under the DLA's pharmaceutical...
- The Defense Logistics Agency awarded a $13,372.43 firm fixed price delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Zepbound 5 mg/0.5 ml pen injections. The contract, which is set to be completed by September 4, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order was awarded competitively without a set-aside designation, reflecting the contractor's demonstrated capability to meet...
- The Defense Logistics Agency awarded a $1,584.34 delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Zepbound 2.5 mg/0.5 mL pens. This firm fixed-price, non-competitive delivery order is set to be completed by August 19, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government's...
- The Defense Logistics Agency awarded a $1,306.78 firm fixed price delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 5 mg/0.5 mL pens. This competitive award, with a completion date of July 30, 2025, represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply arrangements with the federal government. The order will be fulfilled from the vendor's Conshohocken, Pennsylvania location, where the company operates as a major...
- The Defense Logistics Agency awarded a $5,476.25 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Zepbound 7.5 mg/0.5 mL pens. This competitively awarded, firm fixed-price delivery order is scheduled for completion by July 30, 2025, with performance at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract carries no set-aside designation, reflecting the vendor's demonstrated capability to compete in open federal procurement processes for...
- The Defense Logistics Agency awarded a delivery order valued at $13,980.14 to AmerisourceBergen Drug Corp for the supply of Zepbound 5 mg/0.5 mL pens on July 30, 2025. This firm fixed-price delivery order, with an ultimate completion date of July 31, 2025, represents a competitively awarded non-set-aside contract for pharmaceutical supplies to support federal medical procurement needs. The product will be performed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 11, 2025, for the supply of Zepbound 5 mg/0.5 mL pens at a ceiling value of $2,287.74. This contract represents a firm fixed price delivery order with an ultimate completion date of July 14, 2025, and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $29,615.89 to AmerisourceBergen Drug Corp for the supply of Zepbound 2.5 mg/0.5 mL pen injectors on July 28, 2025, with an ultimate completion date of July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a single delivery order transaction for the diabetes medication. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, where the...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB25FC88RDelivery Order
The Defense Logistics Agency awarded a $22,539.19 firm fixed price delivery order to AmerisourceBergen Drug Corp for 5 mg/0.5 mL Zepbound pens on September 3, 2025, with completion scheduled for September 4, 2025. This non-set-aside contract represents a single delivery order for the diabetes medication under the company's broader pharmaceutical supply agreement with DLA. The place of performance is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a wide range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines. The contract supports critical federal healthcare customers including the Defense Health Agency and U.S. Coast Guard, reflecting AmerisourceBergen's role as a major pharmaceutical distributor and key vendor for federal medical procurement needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.5k | 9/3/25 |